T1/ST2 (IL-33R) Mouse, Monoclonal Antibody, FITC

Product Description

T1/ST2 (IL-33R) Mouse, Monoclonal Antibody, FITC
Catalog number: B2026977
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 ug
Molecular Weight or Concentration: NA
Supplied as: Solution
Storage: −20°C
Keywords: DER4, FIT-1, IL-1 R4, IL-1R4, IL-1RL1, IL-33 R, IL-33R, IL1R4, IL33R, Ly84, ST2, ST2L, ST2V, T1

References:
1. Chackerian, A. A., Oldham, E. R., Murphy, E. E., Schmitz, J., Pflanz, S., & Kastelein, J. J. (2007). IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. Journal of Immunology, 179(4), 2551-2555.
2. Schmitz, J., Owyang, A., Oldham, E., Murphy, E., Terrett, N. M., Chen, Y., … & Kastelein, R. A. (2005). IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2. Immunity, 23(5), 479-490.
3. Liew, F. Y., Girard, J. P., & Turnquist, H. R. (2016). Interleukin-33 in health and disease. Nature Reviews Immunology, 16(11), 676-689.
4. Palmer, G., & Gabay, C. (2011). Interleukin-33 biology with special focus on embryogenesis and wound healing. Journal of Dermatological Science, 63(3), 151-156.
5. Trajkovic, V., Sweet, M. J., & Xu, D. (2004). T1/ST2-an inflammatory marker and more. Cytokine & Growth Factor Reviews, 15(2-3), 87-95.
6. Sundnes, O., Pietka, W., Shao, Z., Haugstostoel, M. S., Forbes, G. J., Hol, J., … & Haraldsen, G. (2015). IL-33 is a luminal alarmin that is released from necrotic epithelial cells and is lost from the nuclei of keratinocytes during inflammation. Journal of Investigative Dermatology, 135(7), 1791-1801.
7. Moussion, C., Ortega, N., & Girard, J. P. (2008). The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ‘alarmin’? PloS One, 3(10), e3331.
8. Lott, J. M., Scurlock, A. M., & Norwood, C. L. (2014). IL-33 is an unconventional alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells. The Journal of Immunology, 193(3), 1145-1154.
9. O’Donnell, J. S., Teng, M. W., & Smyth, M. J. (2019). Cancer immunoediting and resistance to T cell-based immunotherapy. Nature Reviews Clinical Oncology, 16(3), 151-167.
10. Tominaga, S. I. (1989). A putative protein of a growth-specific gene from BALB/c-3T3 cells is highly similar to the extracellular portion of interleukin-1 receptor. FEBS Letters, 258(2), 301-304.
T1/ST2 (IL-33R) Mouse, Monoclonal Antibody, FITC

Products Related to T1/ST2 (IL-33R) Mouse, Monoclonal Antibody, FITC can be found at Antibodies